Theme: Translational Targets, Cellular Therapies & Clinical Biomarkers
October 14–15, 2027 Boston, USA (Hybrid Track)
The Annual Colloquium on Precision Oncology & Next-Gen Therapeutics convenes principal investigators, clinical oncologists, and healthcare leaders to dissect clinical trial registries, novel therapeutic targets, and translational biomarkers.
Registered attendees receive verified Educational Contact Hours formatted for institutional appraisal portfolios, while accepted presentation abstracts receive permanent, open-access Zenodo DOIs.
To accelerate clinical translation by providing an uncompromised, peer-reviewed forum where oncology laboratory breakthroughs bridge directly into day-to-day patient hospital protocols.
Faculty members and clinicians can apply as Scientific Session Chairs, Guest Editors for symposium proceedings, or Panel Moderators. Direct submissions are peer-reviewed on a rolling basis.
Early registration tiers are actively open. The preliminary scientific schedule draft will be made accessible to all registered authors 45 days prior to the opening ceremony.
Small molecule kinase inhibitors, antibody-drug conjugates (ADCs), DNA damage repair targets, and overcoming clinical drug resistance.
CAR-T/TCR cell architecture, checkpoint inhibitors, neoantigen cancer vaccines, and strategies for solid tumor microenvironments.
Circulating tumor DNA (ctDNA), minimal residual disease (MRD) monitoring, and digital pathology AI algorithms.
A structured 90-minute hands-on clinical session examining next-generation sequencing (NGS) data interpretations and targeted drug combination workflows for treatment-refractory tumors.
Seat capacity limited to 45 delegates.Dedicated interactive poster sessions scheduled across both days. Authors display longitudinal case studies, clinical trials, and preliminary laboratory findings with peer Q&A.
Includes persistent DOI deposition in proceedings.Registration Check-in, Plenary Addresses, Molecular Pathology & Targeted Therapy Panels
Cellular Therapy Tracks, Poster Defense Gallery, Masterclass, and Official Award Assembly
Keynote Presenter
Director of Molecular Therapeutics
Comprehensive Cancer Center
Keynote Presenter
Lead Investigator, Cell Therapies
Institute of Oncology Research
OCM Chair — Clinical Trials Taskforce
OCM Member — Academic Review Panel
OCM Member — Scientific Syllabus Desk
We partner with pharmaceutical groups, laboratory device manufacturers, and diagnostic developers driving clinical advancements.
Put your diagnostic platforms and clinical solutions directly before oncology decision-makers. Packages include dedicated exhibition booths, workshop sponsorships, and indexed banner placements.
Request Prospectus PDFSubmit original clinical datasets and reviews for peer appraisal. Accepted presentations are deposited with persistent Zenodo DOIs.
All passes include podium admission, indexed proceedings abstract inclusion, and official certificates documenting curriculum-aligned educational contact hours.
| Pass Category | Early Rate | Standard | Instant Registration |
|---|---|---|---|
| Speaker Presentation Pass Oral Podium Slot + Proceedings DOI | $749 | $899 | |
| Delegate / Listener Pass Full 2-Day Session Access | $749 | $799 | |
| Virtual E-Poster Track Remote Abstract + Presentation Credit | $149 | $199 |
🔒 Official invoices and verification letters for grant and institutional reimbursement are issued immediately upon payment completion.
Boston, Massachusetts, USA.
Special negotiated academic accommodation rates are accessible for confirmed conference delegates. Contact the secretariat desk for housing codes.
+1 (Secretariat Desk)